2821 GENES FOUND

Show / hide columns

XML | RDF | TSV | Page of 57 | next »

Gene

 

 

Gene description

x

 

 

 

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

IH abundance (Normal Tissue)

x

RNA abundance (Normal Tissue)

x

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

RNA TS

x

RNA TS TPM

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

A1BGAlpha-1-B glycoprotein
Liver cancer: 3.97e-4
Tissue enriched297liver:505.4
A2MAlpha-2-macroglobulin
Expressed in all
A2ML1Alpha-2-macroglobulin-like 1
Tissue enriched6esophagus:480.8
A4GNTAlpha-1,4-N-acetylglucosaminyltransferase
Tissue enriched8stomach:24.6
AAGABAlpha- and gamma-adaptin binding protein
Nuclear speckles
Cytosol
Renal cancer: 1.36e-4
Thyroid cancer: 9.48e-4
Expressed in all
AANATAralkylamine N-acetyltransferase
CytosolTissue enhancedtestis:4.8
ABCA6ATP-binding cassette, sub-family A (ABC1), member 6
NucleoplasmLiver cancer: 3.29e-4
Tissue enhancedliver:41.4
ABCA7ATP-binding cassette, sub-family A (ABC1), member 7
Golgi apparatus
Plasma membrane
Cell Junctions
Endometrial cancer: 1.12e-4
Colorectal cancer: 7.26e-4
Mixed
ABCG1ATP-binding cassette, sub-family G (WHITE), member 1
Golgi apparatus
Vesicles
Renal cancer: 7.16e-6
Expressed in all
ABHD1Abhydrolase domain containing 1
Tissue enriched17testis:29.9
ABHD10Abhydrolase domain containing 10
MitochondriaRenal cancer: 4.72e-9
Cervical cancer: 7.57e-4
Expressed in all
ABHD14AAbhydrolase domain containing 14A
VesiclesLung cancer: 4.72e-4
Expressed in all
ABHD15Abhydrolase domain containing 15
Nucleoplasm
Cytosol
Mixed
ABHD17AAbhydrolase domain containing 17A
VesiclesPancreatic cancer: 1.76e-5
Endometrial cancer: 1.73e-4
Head and neck cancer: 6.46e-4
Mixed
ABHD17BAbhydrolase domain containing 17BN/A
Renal cancer: 2.59e-4
Expressed in all
ABI3BPABI family, member 3 (NESH) binding protein
Nucleoli
Nuclear speckles
Centrosome
Cytosol
Renal cancer: 6.14e-4
Mixed
ABLIM1Actin binding LIM protein 1
CytosolRenal cancer: 2.72e-5
Expressed in all
ABRActive BCR-related
Nucleoplasm
Cytosol
Renal cancer: 2.21e-4
Cervical cancer: 4.03e-4
Mixed
AC009133.22N/A
Tissue enhancedcolon:2.7
duodenum:1.9
spleen:1.0
AC011513.3
Group enriched7colon:42.9
esophagus:10.4
AC136352.5N/A
Not detected
ACACBAcetyl-CoA carboxylase beta
Renal cancer: 1.15e-5
Pancreatic cancer: 1.93e-4
Tissue enriched6adipose tissue:194.0
ACAD9Acyl-CoA dehydrogenase family, member 9
MitochondriaRenal cancer: 4.32e-8
Liver cancer: 3.67e-6
Endometrial cancer: 3.05e-4
Expressed in all
ACADSAcyl-CoA dehydrogenase, C-2 to C-3 short chain
Nucleoplasm
Mitochondria
Renal cancer: 3.33e-6
Urothelial cancer: 6.34e-5
Liver cancer: 2.43e-4
Endometrial cancer: 5.05e-4
Glioma: 9.94e-4
Expressed in all
ACADVLAcyl-CoA dehydrogenase, very long chain
Nucleus
Nucleoli
Mitochondria
Pancreatic cancer: 6.87e-4
Expressed in all
ACANAggrecan
Renal cancer: 1.47e-6
Tissue enhancedseminal vesicle:5.0
ACAT1Acetyl-CoA acetyltransferase 1
MitochondriaRenal cancer: 0.00e+0
Liver cancer: 1.43e-5
Expressed in all
ACEAngiotensin I converting enzyme
VesiclesTissue enhancedduodenum:183.8
small intestine:297.5
ACHEAcetylcholinesterase (Yt blood group)
Golgi apparatus
Vesicles
Renal cancer: 3.88e-5
Glioma: 7.16e-4
Tissue enhancedskeletal muscle:58.5
ACOT9Acyl-CoA thioesterase 9
Nucleoplasm
Plasma membrane
Cytosol
Liver cancer: 3.23e-4
Expressed in all
ACOX3Acyl-CoA oxidase 3, pristanoyl
PeroxisomesEndometrial cancer: 2.16e-4
Expressed in all
ACOXLAcyl-CoA oxidase-like
N/A
Nucleoli
Cytosol
Urothelial cancer: 6.48e-4
Group enriched5epididymis:9.2
lung:14.6
parathyroid gland:7.4
prostate:5.5
testis:5.3
urinary bladder:8.0
ACP5Acid phosphatase 5, tartrate resistant
CytosolTissue enhancedlung:254.2
ACP6Acid phosphatase 6, lysophosphatidicN/A
Urothelial cancer: 6.44e-4
Expressed in all
ACPPAcid phosphatase, prostate
Tissue enriched153prostate:6368.2
ACRAcrosin
Tissue enriched56testis:115.9
ACRBPAcrosin binding protein
Nucleoplasm
Vesicles
Tissue enriched19testis:432.6
ACRV1Acrosomal vesicle protein 1
Tissue enriched37testis:152.8
ACSF2Acyl-CoA synthetase family member 2
Nucleoplasm
Microtubules
Cytosol
Renal cancer: 2.17e-4
Urothelial cancer: 2.41e-4
Tissue enhancedkidney:136.1
ACSM3Acyl-CoA synthetase medium-chain family member 3
Renal cancer: 9.88e-6
Ovarian cancer: 1.97e-4
Tissue enhancedliver:93.0
ACVR1Activin A receptor, type I
Urothelial cancer: 5.17e-4
Expressed in all
ACVR1CActivin A receptor, type IC
Tissue enriched8adipose tissue:33.9
ACVRL1Activin A receptor type II-like 1
Tissue enhancedplacenta:125.5
ACYP1Acylphosphatase 1, erythrocyte (common) type
Nucleus
Cytosol
Liver cancer: 6.14e-7
Breast cancer: 1.17e-4
Expressed in all
ACYP2Acylphosphatase 2, muscle type
NucleoplasmExpressed in all
ADAM10ADAM metallopeptidase domain 10
Vesicles
Plasma membrane
Lung cancer: 8.46e-5
Pancreatic cancer: 1.90e-4
Expressed in all
ADAM12ADAM metallopeptidase domain 12
Plasma membraneRenal cancer: 2.39e-14
Tissue enriched8placenta:236.1
ADAM15ADAM metallopeptidase domain 15
VesiclesRenal cancer: 5.64e-9
Glioma: 3.49e-5
Liver cancer: 3.49e-4
Expressed in all
ADAM17ADAM metallopeptidase domain 17
CytosolUrothelial cancer: 4.23e-5
Expressed in all
ADAM22ADAM metallopeptidase domain 22
Cell JunctionsTissue enhancedcerebral cortex:47.7

Page of 57 | next »